Italy debt deal no panacea for perennial budget deficit
This article was originally published in Clinica
The debt-repayment deal agreed by the regional health service of Italy's Lazio region will be seen by the many manufacturers burdened by years of delayed payments as a significant light at the end of the tunnel. However, the situation in Italy's third-largest region, with around 9% of the population, is really the tip of the iceberg when taking into account the full extent of the national healthcare industry's budget-balancing problems.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.